NEW YORK (

TheStreet

) --

CHANGE IN RATINGS

Hanesbrands

(HBI) - Get Report

was initiated with a neutral rating at Goldman Sachs. $23 price target. Attractive business but facing several challenges.

Juniper Networks

(JNPR) - Get Report

was upgraded from market perform to outperform at BMO Capital Markets. $25 price target. Valuation call.

ViroPharma

(VPHM)

was initiated with a buy rating at Brean Murray. $37 price target. Stregnth of orphan drug, Cinryze.

Wabco

(WBC) - Get Report

WBC was upgraded to overweight at JPMorgan. Unique buying opportunity.

STOCK COMMENTS / EPS CHANGES

Alcoa

(AA) - Get Report

estimates lowered through 2011, Morgan Stanley said. Should retain defensive appeal despite headwinds. Overweight rating and $13 price target.

Actuant

(ATU)

numbers raised at Jefferies. Shares of ATU now seen reaching $31, Jefferies said. High-quality first quarter and beat. Buy rating.

Bed Bath & Beyond

(BBBY) - Get Report

estimates increased through 2013, UBS said. Solid results and margin expansion. Maintain $64 price target and neutral rating.

CVS Caremark

(CVS) - Get Report

target raised at Goldman Sachs. Shares of CVS now seen reaching $44, Goldman Sachs said. Revived credibility yields confidence in growth algorithm. Buy rating.

Emerson Electric

(EMR) - Get Report

numbers lowered at UBS. Shares of EMR now seen reaching $50, according to UBS. Estimates also lowered on climate weakness and flat year-over-year orders. Neutral rating.

Emerson Electric numbers cut at Citigroup. Shares of EMR now seen reaching $56, according to Citigroup. Estimates also lowered on Thai flood, destocking, and pockets of lower demand. Buy rating.

Emerson Electric target lowered at Goldman Sachs. Shares of EMR now seen reaching $51, Goldman Sachs said. Facing incremental demand weakness. Buy rating.

CarMax

(KMX) - Get Report

numbers lowered Goldman Sachs. Shares of KMX now seen reaching $29, Goldman Sachs said. Estimates also lowered on softer same-store unit trends. Neutral rating.

CarMax estimates, target cut at Deutsche Bank. Shares of KMX now seen reaching $31, according to Deutsche Bank. Estimates also lowered as company missed volume and profit expectations.

Micron Technology

(MU) - Get Report

numbers cut at UBS. Shares of MU now seen reaching $12, according to UBS. Estimates also lowered on DRAM margin erosion. Buy rating.

Micron technology estimates lowered through 2013, Sterne Agee said. Guided NANA-DRAM outlook down. $11 price target and buy rating.

Netflix

(NFLX) - Get Report

estimates, target lowered at Citigroup. Shares of NFLX now seen reaching $80, according to Citigroup. Estimates also lowered on segment rebuild and disclosure about 2012 losses. Neutral rating.

The Shaw Group

(SHAW)

target raised at Goldman Sachs. Shares of SHAW now seen reaching $27, Goldman Sachs said. Improved execution, awards and catalysts prop shares near-term. Neutral rating.

Walgreen

(WAG)

estimates lowered at Guggenheim through 2012. No last ditch settlement with ESRX. Maintain $39 price target and buy rating.

Walgreen Company numbers lowered at Goldman Sachs. Shares of WAG now seen reaching $38, Goldman Sachs said. Estimates also lowered on poor quarter report. Buy rating.

>To submit a news tip, email:

tips@thestreet.com

.

RELATED STORIES:

>>5 Big Stocks to Trade for Gains

>>Wall Street's Most-Wanted Stock Killers of 2011

Follow

TheStreet

on

Twitter

and become a fan on

Facebook.

This article was written by a staff member of RealMoney.com.